The platform for longevity biotech intelligence

Search companies, track assets, monitor signals and generate answers from one specialist data platform.

Already licensed by Top 10 Big Pharmas

What sits underneath every answer

DLT is one linked data model, not a set of separate databases.

Companies, drug assets, targets, patents, financings and people are held as connected records, each mapped to the aging biology it relates to.

A filter, a dashboard and a copilot query therefore all read the same records, and every result stays traceable to the profile it came from.

Companies

Background, technology, leadership, patents and news, with links to similar companies.

Assets and targets

Each asset carried with its target, mechanism, modality, indication, stage and aging relevance.

Capital

Total raised to date information and funding announcements to build capitalization signals

Signals

Trials, IP grants, partnerships, regulatory steps and people moves, timestamped as they land.

INTELLIGENCE COPILOT

The analytical layer at the centre of the platform

The copilot is a retrieval system over DLT’s structured longevity corpus. It reads the same company, asset, patent and financing records the platform browses, and answers only from them.

That is what makes an answer usable in a memo. A question about mTOR companies returns the companies held in the dataset, with the evidence attached, rather than a plausible list assembled from press coverage.

Live

Queries run against the current dataset

100%

Rows traceable to a source record

Minutes

To a briefing that would take days/weeks

HOW IT WORKS

Retrieval, not recall

Each question runs against the live dataset at query time. Nothing is answered from a model’s memory of the internet.

Structured outputs

Answers come back as lists, tables and market maps built from platform records, so counts reconcile with the dashboards.

Auditable to the row

Every company, asset and round in an answer links to the profile behind it, with the date that record was last updated.

PLATFORM CAPABILITIES

And everything underneath it, in seven parts

01 / ADVANCED SEARCH

Find the right companies faster

Search and filter by mechanism, indication, modality, clinical stage, geography, funding, IP, investor profile and more. Every filter narrows a longevity-native dataset, not a generic company index.

Pathway and hallmark-level filters

Saveable searches and shared views

Results link straight into full profiles

02 / COMPANY PROFILES

The whole company in one record

See company background, investment news, leadership, technology, assets, patents, news and similar companies in one profile.

Descriptive detail behind every drug asset

Aging pathways, hallmarks and trial data

Similar-company suggestions

03 / REAL-TIME DASHBOARDS

Turn complex market data into clear visual intelligence

Track company counts, funding activity, drug assets, therapeutic areas, investor activity and market movement from live dashboards.

Stage mix and pathway coverage

Breakouts across the whole dataset

Updated as the dataset changes

05 / AUTOMATED ALERTS

Stay ahead of the signals that change relevance

Stay ahead of company news, funding activity, IP, clinical progress, partnerships and people moves. Create watchlists and receive daily or weekly updates on the companies and themes that matter to you.

Watchlists by company or theme

Daily or weekly digests

Trial, financing, IP, partnership and talent triggers

06 / AI INTELLIGENCE QUERIES

Ask deeper questions of DLT's specialist dataset

Generate company lists, market maps, diligence reports, competitor summaries and strategic briefings using natural-language queries. The copilot runs inside a structured longevity corpus, not a general web index.

Traceable, company-level retrieval

Structured outputs, not prose guesses

Every row links to its source record

07 / REPORTS AND EXPORTS

Take the work out of the platform

Generate charts, summaries and intelligence outputs for investment, licensing, M&A and strategy workflows. Export search results, target lists and company data for offline analysis and internal reporting.

Market maps and diligence briefs

BD target lists sourced from any view

CSV exports for internal models

DATA OPERATIONS

Where the data comes from, and how often it moves

Coverage is curated by the Longevity.Technology research team rather than scraped, which is why the records carry written detail as well as fields.

UPDATE CADENCE

Signal feeds run daily. Company, asset and financing records are reviewed continuously, and each profile shows when it was last updated.

SOURCES

Company disclosures, clinical trial registries, patent offices, financing announcements, regulatory filings and the Longevity.Technology newsroom.

COVERAGE SCOPE

Companies worldwide whose science maps to aging biology, from discovery stage through late clinical development.

ENTITY LINKING

Companies, assets, targets, patents and people are linked, so one filter carries through search, dashboards, alerts and the copilot.

ACCESS

Access is arranged per team after a discovery call. Every arrangement includes the browser platform, alert digests, CSV exports and copilot queries.

WHAT TO EXPECT

Where the data comes from, and how often it moves

The questions teams ask before they commit, answered plainly.

GETTING IN

A browser login. No install, no data warehouse work, nothing to connect before the first query.

SHARING

Searches, watchlists and views can be shared inside your team, so a shortlist survives the person who built it.

GETTING DATA OUT

Any view exports to CSV, JPEG, or PDF. Copilot answers export as written briefs with their source records attached.

WHERE IT STOPS

DLT covers companies whose science maps to aging biology. It is not a general biotech registry.

WHEN IT IS NOT ENOUGH

Questions needing primary interviews or a specific commercial framing go to our research team as a custom report.

IN USE TODAY

Already licensed by Top 10 Big Pharmas

See it run on your question

Bring a mechanism, indication or competitor set and we will show you what DLT holds on it.